House of Doge partners with IP Strategy to build blockchain IP platform

House of Doge, the corporate arm of the Dogecoin Foundation, announced a partnership with IP Strategy Holdings (NASDAQ: IPST) and Brag House Holdings (NASDAQ: TBH) to develop a blockchain-powered intellectual property registration and monetization platform.

The collaboration combines three components: IP Strategy as the U.S. registration portal for on-chain IP registration, House of Doge as the monetization engine built on Dogecoin, and Story as the blockchain infrastructure provider. The platform aims to allow creators and content owners to register and monetize intellectual property using blockchain technology.

The system will enable users to establish ownership records on-chain, with all records owned by individuals rather than centralized platforms. The partnership addresses verification of ownership and compliance challenges that IP owners face when working with brand partners.

"This collaboration represents a fundamental shift in how value is created and shared in the digital economy," said Marco Margiotta, CEO of House of Doge. "Our goal is simple: give creators and content owners the tools to engage their audiences, activate their IP, and directly benefit from the ecosystems they help build."

Justin Stiefel, CEO of IP Strategy, stated the platform will allow creators to "establish verifiable ownership, unlock compliant monetization, and access a truly global marketplace for their IP rights."

The platform will provide immutable transaction records, transparent payment tracking, and compliance tools for brand partnerships. House of Doge will handle commercialization efforts including monetization tools and customer engagement, while Story provides the blockchain infrastructure for registration and royalty distribution.

IP Strategy Holdings is the first NASDAQ-listed company to hold $IP tokens as a primary reserve asset and operates a validator for the Story Blockchain. Story raised $136 million from investors including a16z crypto, Polychain Capital, and Samsung Ventures.

You May Also Be Interested In

• FDA Committee Recommends To Widen Access To Bpc-157 Peptide
• LakeShore Biopharma (LSB) 3400 contracts of August 12.50 calls
• U.S. to begin rulemaking aimed at shoring up car door safety - Bloomberg